TP53 and thyroid cancer: Of them, cyclin-dependent kinase inhibitor p21 attracted our attention because it is a well-characterized downstream effector of p53, and functions as a tumor suppressor by inducing cell cycle arrest in tumorigenesis including thyroid cancer 19, 45.